Search by Drug Name or NDC

    NDC 68180-0296-03 Duloxetine 60 mg/1 Details

    Duloxetine 60 mg/1

    Duloxetine is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is DULOXETINE HYDROCHLORIDE.

    Product Information

    NDC 68180-0296
    Product ID 68180-296_d87ec3ae-b1d4-4419-b47d-12375d7aa77e
    Associated GPIs 58180025106750
    GCN Sequence Number 057893
    GCN Sequence Number Description duloxetine HCl CAPSULE DR 60 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 23164
    HICL Sequence Number 026521
    HICL Sequence Number Description DULOXETINE HCL
    Brand/Generic Generic
    Proprietary Name Duloxetine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Duloxetine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 60
    Active Ingredient Units mg/1
    Substance Name DULOXETINE HYDROCHLORIDE
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090694
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0296-03 (68180029603)

    NDC Package Code 68180-296-03
    Billing NDC 68180029603
    Package 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68180-296-03)
    Marketing Start Date 2013-12-11
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.1154
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description DULOXETINE HCL DR 60 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis